Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats
Translational Vision Science & Technology · 2023
DOI: 10.1167/tvst.12.8.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von Hyemin Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Surgery and Ophthalmology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Exosomes, Mesenchymal Stem Cells, Cataract. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Diabetic retinopathy (DR) is an important disease that causes vision loss in many diabetic patients. Stem cell therapy has been attempted for treatment of this disease; however, it has some limitations. This study aimed to evaluate the preventive efficacy of exosome-rich conditioned medium (ERCM) derived from amniotic membrane stem cells for DR in rats.
Methods
Twenty-eight 8-week-old male Sprague-Dawley rats were divided into three groups: group 1, normal control (Con) group; group 2, diabetes mellitus (DM) group; and group 3, DM with ERCM-treated (DM-ERCM) group. DM was induced by intraperitoneal injection of streptozotocin. The DM-ERCM group received ERCM containing 1.2 × 10⁹ exosomes into subconjunctival a total of four times every 2 weeks.
Results
On electroretinogram, the DM-ERCM group had significantly higher b-wave and flicker amplitudes than those in the DM group. In fundoscopy, retinal vascular attenuation was found in both the DM and DM-ERCM groups; however, was more severe in the DM group. On histology, the ganglion cell and nerve fiber layer rates of the total retinal layer significantly increased in the DM group compared with the Con group, whereas the DM-ERCM group showed no significant difference compared with the Con group. Cataracts progressed significantly more in the DM group than that in the DM-ERCM group and there was no uveitis in the DM-ERCM group.
Conclusions
Subconjunctival ERCM delayed the progression of DR and cataracts and significantly reduced the incidence of uveitis. Translational Relevance: Our study shows the clinical potential of minimally invasive exosome-rich conditioned medium treatment to prevent diabetic retinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Surgery and Ophthalmology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea.
- Laboratory of Toxicology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea.
- Central Research Institute, Designed Cells Co., Ltd., Cheongju, Korea.
Zitieren
APA
Kim, H., Goh, Y. S., Park, S. E., Hwang, J., Kang, N., Jung, J. S., Kim, Y. B., Choi, E. K., & Park, K. M. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.8.18
Vancouver
Kim H, Goh YS, Park SE, Hwang J, Kang N, Jung JS, et al. Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.8.18
BibTeX
@article{Kim2023,
author = {Kim, Hyemin and Goh, Yeong-Seok and Park, Sang-Eun and Hwang, Jiyi and Kang, Nanyoung and Jung, Ji Seung and Kim, Yun-Bae and Choi, Ehn-Kyoung and Park, Kyung-Mee},
title = {Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats},
journal = {Translational Vision Science & Technology},
year = {2023},
doi = {10.1167/tvst.12.8.18}
}
EUVIMED